Clinicopathological characteristics and prognostic significance of casting-type calcifications in patients with invasive breast cancer presenting with microcalcification
Wang, Jiang, Zhao, Liangying, Hu, Xiaoshan, Lv, Liting, Zhang, Xiaowei, Lu, Minjun, Hu, Guinv
Published in Scientific reports (10.06.2024)
Published in Scientific reports (10.06.2024)
Get full text
Journal Article
Methylation-Driven Genes Identified as Novel Prognostic Indicators for Thyroid Carcinoma
Lv, Liting, Cao, Liyu, Hu, Guinv, Shen, Qinyan, Wu, Jinzhong
Published in Frontiers in genetics (31.03.2020)
Published in Frontiers in genetics (31.03.2020)
Get full text
Journal Article
Unraveling the impact of social determinants of health on HER2+ early breast cancer screening and treatment in a county oncology setting in China
Ji, Yinghua, Zhou, Feidu, Qu, Honglan, Wu, Qianfu, Liang, Wei, Liu, Mengyou, Wang, Juan, Luo, Jun, Tan, Xiang, Dai, Guohua, Hu, Guinv, Meng, Qiuli, He, Wenbo, Wang, Hongjian, Qin, Zien, Luo, Guoxiang, Tang, Huali, Ren, Yun, Liu, Hui, Tian, Yinguo
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
miR-125b regulates the drug-resistance of breast cancer cells to doxorubicin by targeting HAX-1
Hu, Guinv, Zhao, Xiaokang, Wang, Jiang, Lv, Liting, Wang, Chaoqun, Feng, Liang, Shen, Liangqiong, Ren, Weili
Published in Oncology letters (01.02.2018)
Published in Oncology letters (01.02.2018)
Get full text
Journal Article
The population characteristic analysis in RecurIndex for clinical decision-making on adjuvant therapy for early breast cancer: Results of a real-world study
Wang, Xiaojia, Lei, Lei, Fu, Peifen, Wang, Ouchen, Xie, Xiaohong, Xu, Haibin, Feng, Weiliang, Yang, Hongjian, Hu, Guinv, Li, Shuguang, Dai, Zhijun, Guo, Guilong, Lv, Xiaoai, Zheng, Ya-bing, Chen, Zhan-hong, Shao, Xi-Ying
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Abstract OT2-14-01: Pyrotinib after trastuzumab-based adjuvant therapy in high-risk early human epidermal growth factor receptor 2-positive breast cancer: a multicenter phase 2 trial
Cao, Feilin, Ma, Zhaosheng, Hu, Guinv, Zhu, Xiaotao, Li, Shuguang, Chen, Shuzheng, Chen, Binglie, Li, Zhanwen, Wu, Weizhu, Ji, Xiaochun, Shu, Jingde, Tao, Deyou, Hu, Xiaoqing, Zheng, Min, Wang, Ouchen, Feng, Qingjing, Hao, Jing, Li, Xujun
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Get full text
Journal Article
Abstract PO2-16-08: Adjuvant Treatment Selection for County-Level Patients with HR+/HER2- Early Breast Cancer in a Real-Life Setting in China
Ji, Yinghua, Qu, Honglan, Zhou, Feidu, Wang, Juan, Wu, Qianfu, Dai, Guohua, Liu, Mengyou, He, Wenbo, Liang, Wei, Meng, Qiuli, Ren, Yun, Luo, Guoxiang, Wang, Hongjian, Liu, Hui, Qin, Zien, Tian, Yingguo, Tang, Huali, Liu, Hongmei, Luo, Jun, Yu, Zengfeng, Hu, Guinv, Gao, Jianzhi, Tan, Xiang, Liu, Yi, Zhang, Yuanjiang, Wang, Ming, Zhang, Min, Lu, Ping
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Get full text
Journal Article